Evidence map›Paper›PMID 36130263›Full record

ArticleG3 (Bethesda, Md.)2022

Analysis of Cyp51 protein sequences shows 4 major Cyp51 gene family groups across fungi.

Brandi N Celia-Sanchez, Brandon Mangum, Marin Brewer, Michelle Momany

Open access · goldAbstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Plants (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Deciphering the multidrug resistance paradigm inAntimicrobial agents and chemotherapy · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The micromammals.G3 (Bethesda, Md.) · 2024
    Article
  13. Pan-azole- and multi-fungicide-resistantApplied and environmental microbiology · 2024
    Article
  14. Fungicide Sensitivity Profile ofJournal of fungi (Basel, Switzerland) · 2024
    Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Brandi N Celia-SanchezDepartment of Plant Biology, University of Georgia, Athens, GA 30606, USA.ORCID 0000-0002-8727-1262
Brandon MangumDepartment of Plant Biology, University of Georgia, Athens, GA 30606, USA.
Marin BrewerDepartment of Plant Pathology, University of Georgia, Athens, GA 30606, USA.ORCID 0000-0002-7064-6021
Michelle MomanyDepartment of Plant Biology, University of Georgia, Athens, GA 30606, USA.ORCID 0000-0001-7110-063X
University of Georgia · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Azole drugs target fungal sterol biosynthesis and are used to treat millions of human fungal infections each year. Resistance to azole drugs has emerged in multiple fungal pathogens including Candida albicans, Cryptococcus neoformans, Histoplasma capsulatum, and Aspergillus fumigatus. The most well-studied resistance mechanism in A. fumigatus arises from missense mutations in the coding sequence combined with a tandem repeat in the promoter of cyp51A, which encodes a cytochrome P450 enzyme in the fungal sterol biosynthesis pathway. Filamentous members of Ascomycota such as A. fumigatus have either 1 or 2 of 3 Cyp51 paralogs (Cyp51A, Cyp51B, and Cyp51C). Most previous research in A. fumigatus has focused on Cyp51A due to its role in azole resistance. We used the A. fumigatus Cyp51A protein sequence as the query in database searches to identify Cyp51 proteins across fungi. We found 435 Cyp51 proteins in 295 species spanning from early-diverging fungi (Blastocladiomycota, Chytridiomycota, Zoopagomycota, and Mucormycota) to late-diverging fungi (Ascomycota and Basidiomycota). We found these sequences formed 4 major Cyp51 groups: Cyp51, Cyp51A, Cyp51B, and Cyp51C. Surprisingly, we found all filamentous Ascomycota had a Cyp51B paralog, while only 50% had a Cyp51A paralog. We created maximum likelihood trees to investigate the evolution of Cyp51 in fungi. Our results suggest Cyp51 is present in all fungi with 3 paralogs emerging in Pezizomycotina, including Cyp51C which appears to have diverged from the progenitor of the Cyp51A and Cyp51B groups.

Indexed as

AscomycotaDrug Resistance, FungalAntifungal AgentsAspergillus fumigatusAzolesCytochrome P450 Family 51Fungal ProteinsHumansMicrobial Sensitivity TestsSterolsAntifungal AgentsAzolesCytochrome P450 Family 51Fungal ProteinsSterolsazole resistanceCyp51Cyp51ACyp51BCyp51C

Identifiers

PMID36130263
PMCPMC9635630
OpenAlexW4296703634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.